Kalvista Pharmaceuticals Inc (KALV)
Operating Cash Flow Growth
212.39%
Quarterly · Period ending:
KALV Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported212.39%period ending
Latest reported212.39%period ending
KALV Quarterly Cash from Operations YoY % (-320.25% → 212.39%)
Year-over-year change
High-resolution chart · PNG
KALV operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 212.3873% | |
| 55.7694% | |
| 17.5597% | |
| -35.5097% | |
| -167.2228% | |
| -18.534% | |
| -99.9596% | |
| -50.4676% | |
| 33.27% | |
| -196.8134% | |
| 3.7341% | |
| -17.5358% | |
| 15.5026% | |
| 33.9566% | |
| -5.3671% | |
| -28.2323% | |
| -142.5441% | |
| -85.4073% | |
| -145.7872% | |
| -394.2865% | |
| 12.4663% | |
| 42.1314% | |
| -1.7661% | |
| 68.1774% | |
| -20.0457% | |
| -20.7535% | |
| 11.0631% | |
| -81.5035% | |
| -76.5071% | |
| -138.4692% | |
| -21.036% | |
| -39.6583% | |
| -125.4828% | |
| 251,145.2807% | |
| -349.1955% | |
| 38.7328% | |
| 48.0527% | |
| 99.7782% | |
| 69.5439% | |
| -12.7154% | |
| -25.5619% | |
| -16.8319% | |
| -64.5782% | |
| -232.3529% | |
| -130.8438% | |
| -320.2519% |